Clinical Trial Update: An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis

View source ↗

Summary

An fMRI study comparing two disease-modifying therapies for relapsing-remitting multiple sclerosis was terminated. The trial assessed treatment optimization usi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Neurognostics | Conditions: Relapsing-Remitting Multiple Sclerosis | Status: TERMINATED